Close Button Icon
Doptelet (avatrombopag) Tablets Logo

You are about to leave DOPTELETHCP.com and go to an external page.

Please note that Sobi is not responsible for the content of the website you are about to visit.

CONTINUE

Go back

This information is intended for healthcare professionals in the United States.

Are you a healthcare professional?

Yes

No
Close Button Icon

Discover the Doptelet Copay Program

Eligible commercially insured patients may qualify for the Doptelet Connect program

What's the program?

  • Eligible patients may pay as little as $0 for each Doptelet prescription
  • Annual maximum benefit up to $15,000

Eligible patients must:

  • Have commercial insurance that covers Doptelet
  • Not be enrolled in any state or federal healthcare program such as Medicare, Medicaid, Medigap, Veterans Affairs (VA), Department of Defense (DOD), or TRICARE
  • Be 18 years of age or older
  • Be a resident in the United States or a US Territory

How to enroll:

  • Approved pharmacies, healthcare professionals, and Doptelet Connect can enroll patients
  • Patients can enroll themselves as well as their caregivers
  • Please call 1-833-368-2663 Monday–Friday 8 am–8 pm ET for more information

Terms and Conditions

  • Patients pay as little as $0 per prescription. Copay Program has an annual calendar cap of $15,000
  • The Copay Saving Program is void where prohibited by law, taxes, or restricted
  • This offer is non-transferable, no substitutions are permissible, and this offer cannot be combined with any other rebate/coupon, free trial, or similar offer for the specified prescription
  • Sobi, Inc. reserves the right to rescind, revoke, or amend this offer at any time without notice
  • The Patient Copay Program for Doptelet is not insurance and is not intended to substitute for insurance
  • Patients, pharmacists, and healthcare providers must not seek reimbursement from health insurance or any third party for any part of the benefit received by the patient through this Copay Program. Patients must not seek reimbursement from any health savings, flexible spending, or other healthcare reimbursement accounts for the amount of assistance received from the Copay Program
  • Certain information pertaining to your use of the Copay Program will be shared with Sobi, Inc., the sponsor of the Copay Program. The information disclosed will include the date the prescription is filled, the number of pills or product dispensed by the pharmacists, and the amount of your copay that will be paid for by using this Copay Program. For more information, please see the Sobi Privacy Policy at https://sobi-northamerica.com/privacy-policy
  • Acceptance in this Program is not conditioned on any past, present, or future purchase, including additional doses
  • Enrollment for the Copay Program is valid through the calendar year
  • Sobi reserves the right to change program terms at any time
Close Button Icon
  • For US healthcare professionals only

  • Prescribing Information
  • Patient Information Leaflet
  • For Patients
Doptelet (avatrombopag) Tablets Logo

For Colorado Prescribers

Information for Colorado Prescribers of Prescription Drugs Provided Pursuant to Colorado House Bill 19-1131

SHARING WITH COLORADO PRESCRIBERS

PRICING AND GENERIC EQUIVALENT INFORMATION

IN CONNECTION WITH PRESCRIPTION DRUG MARKETING

Pursuant to Colorado House Bill 19-1131 (and codified in Colorado Revised Statutes 12-42.5-308 and 12-280-308), the following information is being shared with Colorado prescribers (as defined by Colorado HB 19-1131) in connection with prescription drug marketing activities.

Prescription Drug Name: Doptelet® (avatrombopag)

Manufacturer Name: AkaRx, Inc., a wholly-owned subsidiary of Sobi, Inc.

Wholesale Acquisition Cost (WAC) of Doptelet® (avatrombopag): $373.34 (tablet)*

Generic Prescription Drugs from the same therapeutic class (as defined by HB 19-1131): None

IMPORTANT NOTES:

  • WAC based on current price as of July 1, 2022
  • The WAC listed does not necessarily reflect price per dosage, price per course of treatment or the cost effectiveness
  • Please refer to the product’s FDA-approved label and indication for further information
Sobi Rare Strength Logo
Terms of Use
Privacy Policy
Contact Us
Unsubscribe

Doptelet is a registered trademark of AkaRx, Inc., a Sobi company
Sobi is a trademark of Swedish Orphan Biovitrum AB (publ)
Doptelet Connect is a trademark of AkaRx, Inc.
© 2022 Sobi, Inc. – All rights reserved

PP-16809   10/22

This website uses cookies. By continuing to use this website, you consent to our use of these cookies.

Read more about our use of cookies